ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2026
Multimorbidity patterns among fragility fracture patients aged 50 + years in China and the US.
Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
We examined the multimorbidity patterns among fragility fracture patients in China and the US. Except for female fracture patients in US, hyperlipidemia was the most prevalent comorbidity among fracture patients in China and the US. US fracture patients demonstrated a similar complex comorbidity network to non-fracture individuals. PURPOSE: To examine the multimorbidity patterns among fragility fracture patients aged 50 + years in China and the US.
methodsWe extracted inpatient electronic medical records at the First Affiliated Hospital of Jinzhou Medical University, China between 2018 and 2023, and data from the National Health and Nutrition Examination Survey (NHANES) 1999-2020. Fragility fracture patients aged ≥ 50 years were identified. In the NHANES, we matched each fracture patient with a non-fracture individual by age (< 1 year), sex and survey cycle. We identified 28 and 19 chronic diseases in the Chinese and NHANES databases, respectively. Average degree was used to characterize the complexity of comorbidity network.
resultsA total of 2086 Chinese fracture patients, 1227 US fracture and 1227 non-fracture individuals were included (73% females). The most prevalent comorbidity among Chinese fracture patients was hyperlipidemia (male: 63.3%; female: 65.2%). In US fracture patients, the most prevalent comorbidity was hyperlipidemia (67.3%) in males and osteoporosis (78.3%) in females. The most prevalent disease pair was osteoporosis and hyperlipidemia among US fracture patients (male: 40.8%; female: 61.4%), and hypertension and hyperlipidemia among Chinese fracture patients (male: 26.6%; female: 29.4%). The multimorbidity pattern of US fracture patients was similar to that of non-fracture individuals (average degree: 7.82 vs. 7.59 in males; 7.94 vs. 7.44 in females).
conclusionExcept among female fracture patients in the US, hyperlipidemia was the most prevalent comorbidity among Chinese and US fragility fracture patients. US fracture patients demonstrated a similar complex comorbidity network to non-fracture individuals.
Indexed as
Identifiers
42342916What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.